No question CUV is not overvalued. I came across a technology index the other day that included PME (amongst many other high flying techs). So perhaps some of the price action in PME relates to it's technology and index funds in that area. Notwithstanding a solid company with similar solid financial metrics akin to CUV. I wish I had some PME but the growth prospects for CUV are astronomical if things come together. PME need to hold their apparent market leadership. Competition for both is an issue but I like CUV's market position for many years to come with ever increasing and revolving income streams. An update around stroke or DNA repair would rocket things from here IMO. End of year results alone should see CUV back to around $30 if markets behave IMO. GLTA
Shorts - general info, page-339
-
- There are more pages in this discussion • 410 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
0.340(2.48%) |
Mkt cap ! $703.5M | |||
| Open | High | Low | Value | Volume |
| $13.90 | $14.20 | $13.71 | $727.8K | 51.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 167 | $13.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.06 | 789 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |